Does CANAGLIFLOZIN Cause Obesity? 24 Reports in FDA Database

Q: Does CANAGLIFLOZIN cause Obesity?

24 reports of Obesity have been filed with the FDA for CANAGLIFLOZIN, representing 0.1% of all CANAGLIFLOZIN adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Obesity have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.1% of all adverse event reports for CANAGLIFLOZIN.

Reports of Obesity with CANAGLIFLOZIN

0.1%

of all CANAGLIFLOZIN reports

Deaths

Hospitalizations

How Dangerous Is Obesity From CANAGLIFLOZIN?

Of the 24 reports, 18 (75.0%) required hospitalization.

Is Obesity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 24 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,413) Toe amputation (2,193) Osteomyelitis (2,146) Acute kidney injury (1,853) Fungal infection (1,385) Gangrene (1,081) Weight decreased (1,014) Cellulitis (1,007) Urinary tract infection (920) Diabetic foot infection (832)

What Other Drugs Cause Obesity?

RISPERIDONE (3,039) PREDNISONE (1,880) METHOTREXATE (1,876) ADALIMUMAB (1,780) TOCILIZUMAB (1,630) ABATACEPT (1,605) INFLIXIMAB (1,536) HYDROXYCHLOROQUINE (1,532) SULFASALAZINE (1,455) ETANERCEPT (1,407)

Which CANAGLIFLOZIN Alternatives Have Lower Obesity Risk?

CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN CANAGLIFLOZIN vs CANAKINUMAB CANAGLIFLOZIN vs CANDESARTAN CANAGLIFLOZIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE

CANAGLIFLOZIN Full Profile All Obesity Reports All Drugs Causing Obesity CANAGLIFLOZIN Demographics